Institutional investors purchased a net $3.8 million shares of NLNK during the quarter ended March 2014. This may signal that the smart money is gaining interest in this company as the 52.64% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
PYRAMIS GLOBAL ADVISORS (CANADA)... Bought 123.4 Thousand shares of NewLink Genetics Corp
CREDIT SUISSE AG Bought 696.00 shares of NewLink Genetics Corp
STATE TEACHERS RETIREMENT SYSTEM... Bought 400.00 shares of NewLink Genetics Corp